Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility

Molecular Biology Reports

Volumn 40, Issue 5, 2013, Pages 3757-3768

  Mohamed, Faten Zahran ^a   Hussien, Yousry Mostafa ^b   Albakry, Mohamad Mohamad ^b   Mohamed, Randa H ^b   Said, Noha Mohamed ^a  

^a Zagazig University   (Egypt)

^b ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

CDKN1B; ERCC2; Ovarian cancer; RFLP PCR; XRCC2

Indexed keywords

CA 125 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CELL CYCLE REGULATION; CLINICAL FEATURE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; XRCC2 GENE;

ADULT; CA-125 ANTIGEN; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OVARIAN NEOPLASMS; RISK; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84878378573     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2452-8     Document Type: Article

References (32)

1. Auranen A, Pukkala E, Makinen J, Sankila R, Grenman S (1996) Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer 74:280-284
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J et al (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85
3. Ford D, Easton DF, Stratton M, Narod S, Goldgar D et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676-689
4. Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF et al (1999) The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes. Am J Hum Genet 65:1021-1029
5. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA (1998) A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 105:493-499
6. Antoniou AC, Easton DF (2006) Risk prediction models for familial breast cancer. Future Oncol 2:257-274
7. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF et al (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33-36
8. Dicioccio RA, Song H, Waterfall C, Kimura MT, Nagase H et al (2004) STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiol Biomark Prev 13:1589-1594
9. Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B et al (2005) Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int J Cancer 117(6):611-618
10. Song H, Ramus SJ, Shadforth D, Quaye L, Kjaer SK et al (2006) Common variants in RB1 gene and risk of invasive ovarian cancer. Cancer Res 66(20):10220-10226
11. Song H, Ramus SJ, Kjaer SK, Hogdall E, Dicioccio RA et al (2007) Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer. PLoS ONE 2(3):e268
12. Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS et al (2007) Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 67(7):3027-3035
13. Hu JJ, Smith TR, Miller MS, Lohman K, Case LD (2002) Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen 39:208-215
14. Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA, Sanford KK (1996) Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 74(1):1-5
15. Debniak T, Scott RJ, Huzarski T, Byrski T, Masojc B, van de Wetering T, Serrano-Fernandez P, Gorski B, Cybulski C, Gronwald J, Debniak B, Maleszka R, Kladny J, Bieniek A, Nagay L, Haus O, Grzybowska E, Wandzel P, Niepsuj S, Narod SA, Lubinski J (2006) XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat 98:209-215
16. de Boer JG (2002) Polymorphisms in DNA repair and environmental interactions. Mutat Res 509:201-210
17. Berwick M, Vineis P (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92:874-897
18. Costa S, Pinto D, Pereira D, Vasconcelos A, Afonso-Lopes C, Osorio T, Lopes C, Medeiros R (2007) Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer. Cancer Lett 246:324-330
19. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA (2000) XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21:551-555
20. Tang D, Cho S, Rundle A, Chen S, Phillips D, Zhou J, Hsu Y, Schnabel F, Estabrook A, Perera FP (2002) Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAHDNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 75:159-166
21. Justenhoven C, Hamann U, Pesch B, Harth V, Rabstein S, Baisch C, Vollmert C, Illig T, Ko YD, Bruning T, Brauch H (2004) ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomark Prev 13:2059-2064
22. Silva SN, Tomar M, Paulo C, Gomes BC, Azevedo AP, Teixeira V, Pina JE, Rueff J, Gaspar JF (2010) Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiol 34(1):85-92
23. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J (2009) Validating genetic risk associations for ovarian cancer through the international ovarian cancer association consortium. Br J Cancer 100(2):412-420
24. Funk JO (1999) Cancer cell cycle control. Anticancer Res 19:4772-4780
25. Lundberg AS, Weinberg RA (1999) Control of the cell cycle and apoptosis. Eur J Cancer 35:1886-1894
26. Sutherland RL, Musgrove EA (2004) Cyclins and breast cancer. J Mammary Gland Biol Neoplasia 9:95-104
27. Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, Rider DN, White KL, Pankratz VS (2009) Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer Epidemiol Biomark Prev. 18(3):935-944
28. Bernard-Gallon D, Bosviel R, Delort L, Fontana L, Chamoux A, Rabiau N, Kwiatkowski F, Chalabi N, Satih S, Bignon YJ (2008) DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer 7:36
29. Costa S, Pinto D, Pereira D, Vasconcelos A, Afonso-Lopes C, Osório T, Lopes C, Medeiros R (2006) Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer. Cancer Lett 246(1-2):324-330
30. Quaye L, Tyrer J, Ramus SJ, Song H, Wozniak E, DiCioccio RA, McGuire V, Høgdall E, Høgdall C, Blaakaer J, Goode EL, Schildkraut JM, Easton DF, Krüger-Kjaer S, Whittemore AS, Gayther SA, Pharoah PD (2009) Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. PLoS ONE 4(6):e5983
31. Fasching PA, Gayther S, Pearce L, Schildkraut JM, Goode E, Thiel F, Chenevix-Trench G, Chang-Claude J, Wang-Gohrke S, Ramus S, Pharoah P, Berchuck A, OCAC (Ovarian Cancer Association Consortium) (2009) Role of genetic polymorphisms and ovarian cancer susceptibility. Mol Oncol 3(2):171-181
32. Jin X, Kang S, Wang N, Xing YP, Li Y (2008) Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer. Zhonghua Fu Chan Ke Za Zhi 43(3):209-212